Fabio
4.4 KiB
type, title, description, jurisdiction, legislature, session, identifier, citation, classification, subjects, status, primary_sponsors, version_count, action_count, vote_count, first_action, last_action, source, source_identifier, source_url, source_hash, vintage, source_snapshot, retrieved_at, confidence, tags
| type | title | description | jurisdiction | legislature | session | identifier | citation | classification | subjects | status | primary_sponsors | version_count | action_count | vote_count | first_action | last_action | source | source_identifier | source_url | source_hash | vintage | source_snapshot | retrieved_at | confidence | tags | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bill | AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO CANCER COVERAGE. | This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual. | us/states/de | Delaware General Assembly | 152 | HB 364 | Delaware HB 364 (152) |
|
enacted |
|
1 | 7 | 2 | 2024-04-11 | 2024-08-02 | openstates | ocd-bill/f40fab38-282b-4a92-a4df-be27dbcd018d | https://legis.delaware.gov/BillDetail?LegislationId=141172 | 500a0a42726f53a34f45bce3ad6ff2227fe007bb9a5c88522db0f7d71c248083 | 2026-07-01 | https://data.openstates.org/daily/2026-07-01/public.pgdump | 2026-07-06 | reported |
|
Delaware HB 364 (152) — AN ACT TO AMEND TITLE 18 OF THE DELAWARE CODE RELATING TO CANCER COVERAGE.
This Act requires that individual, blanket, and group health insurance carriers cover drug treatment for the associated conditions of metastatic cancer in the same way treatment for metastatic cancer is covered. Specifically, it requires insurance companies to cover any FDA approved drug prescribed to treat the side effects of metastatic cancer treatment and prohibits insurance companies from mandating that patients first fail to respond to a different drug or prove a history of failure of such drug. Technical changes are also made to comply with the Delaware Legislative Drafting Manual.
Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
- Bill Text (committee substitute) — source
Votes
- SM — 39–0 (pass) · lower
- 3/5 — 21–0 (pass) · upper
Sponsors
- Cyndie Romer — primary (person)
- David P. Sokola — primary (person)
- Eric Morrison — primary (person)
- Madinah Wilson-Anton — primary (person)
- Nicole Poore — primary (person)
- Paul S. Baumbach — primary (person)
- Peter C. Schwartzkopf — primary (person)
- Russell Huxtable — primary (person)
- Sherry Dorsey Walker — primary (person)
- Spiros Mantzavinos — primary (person)
- Timothy D. Dukes — primary (person)
- William Bush — primary (person)
- William J. Carson — primary (person)
Timeline
The legislative action history — every referral, reading, and vote.
- 2024-04-11 Introduced and Assigned to Economic Development/Banking/Insurance & Commerce Committee in House
introduction, referral-committee - 2024-04-16 Reported Out of Committee (Economic Development/Banking/Insurance & Commerce) in House with 5 Favorable, 4 On Its Merits
committee-passage, committee-passage-favorable - 2024-06-11 Passed By House. Votes: 39 YES 2 ABSENT
passage - 2024-06-11 Assigned to Banking, Business, Insurance & Technology Committee in Senate
introduction, referral-committee - 2024-06-18 Reported Out of Committee (Banking, Business, Insurance & Technology) in Senate with 1 Favorable, 5 On Its Merits
committee-passage, committee-passage-favorable - 2024-06-25 Passed By Senate. Votes: 21 YES
passage - 2024-08-02 Signed by Governor
executive-signature
Source
OpenStates / OpenCivicData bulk snapshot 2026-07-01; origin ocd-bill/f40fab38-282b-4a92-a4df-be27dbcd018d. Confidence: reported (aggregated from official Delaware legislature records).